Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma.

Cunte ChenSichu LiuXinmiao JiangLing HuangFeili ChenXiaojun WeiHanguo GuoYang ShaoYangqiu LiWenyu Li

Published in: Experimental hematology & oncology (2021)

We established GP69 for the evaluation of OS for Chinese DLBCL patients. panel-TMB might be a potential predictor for prognostic stratification of DLBCL patients.

Keyphrases

diffuse large b cell lymphoma
end stage renal disease
ejection fraction
chronic kidney disease
epstein barr virus
gene expression
patient reported outcomes
human health